You have 9 free searches left this month | for more free features.

Methicillin-resistant Staphylococcus aureus

Showing 1 - 25 of 5,972

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Initial and Chronic Methicillin Resistant Staphylococcus Aureus

Completed
  • Methicillin-Resistant Staphylococcus Aureus
  • Cystic Fibrosis
  • Intervention N/A. Observational study
  • Birmingham, Alabama
  • +2 more
Jan 19, 2022

Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)

Not yet recruiting
  • Multidrug Resistant Bacterial Infection
  • +4 more
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Nov 17, 2022

Methicillin-resistant Staphylococcus Aureus Infection Trial in Falls Church, Leesburg (Preoperative MRSA screening)

Terminated
  • Methicillin-resistant Staphylococcus Aureus Infection
  • Preoperative MRSA screening
  • Falls Church, Virginia
  • +1 more
Jun 3, 2021

MRSA Bloodstream Infection, MRSA Bacteremia, MRSA Right-sided Endocarditis Trial in Butte, Toledo (Exebacase)

No longer available
  • MRSA Bloodstream Infection
  • +3 more
  • Butte, Montana
  • +1 more
Aug 25, 2022

CA-MRSA Transmission: An ED Population Sampling Strategy

Recruiting
  • Methicillin-Resistant Staphylococcus Aureus
  • Acute Abscess Group
  • Gainesville, Florida
    UF Health
Jun 4, 2021

Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus Trial in Cleveland (Vancomycin)

Withdrawn
  • Cystic Fibrosis
  • Methicillin-resistant Staphylococcus Aureus
  • Cleveland, Ohio
    Rainbow Babies and Children's Hospital, Univeristy Hospitals Cas
Dec 23, 2021

Infection Control Trial in Baltimore (Enhanced cleaning of surfaces in ICU rooms, Sham enhanced cleaning of surfaces in ICU

Completed
  • Infection Control
  • Enhanced cleaning of surfaces in ICU rooms
  • Sham enhanced cleaning of surfaces in ICU rooms
  • Baltimore, Maryland
    University of Maryland, Baltimore
Feb 15, 2022

Healthy Volunteers, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus Aureus Trial in Seoul (N-Rephasin® SAL200,

Completed
  • Healthy Volunteers
  • +3 more
  • N-Rephasin® SAL200
  • INT200-Placebo
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 26, 2021

Bacteremia Due to Staphylococcus Aureus, Left Sided Infective Endocarditis (Disorder), Right Sided Infective Endocarditis

Withdrawn
  • Bacteremia Due to Staphylococcus Aureus
  • +3 more
  • Tonabacase (LSVT-1701)
  • Butte, Montana
    Lsvt-1701-2001
Jun 27, 2022

Healthy Volunteers, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus Aureus Trial in Seoul (N-Rephasin® SAL200,

Completed
  • Healthy Volunteers
  • +2 more
  • N-Rephasin® SAL200
  • INT200-Placebo
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 7, 2021

Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus Trial in Paris (Cloxacillin, Cefazolin)

Recruiting
  • Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus
  • Paris, France
    François-Xavier Lescure
Dec 7, 2022

Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections Trial in Worldwide

Recruiting
  • Methicillin-Resistant Staphylococcus Aureus
  • +2 more
  • Dalbavancin single dose
  • +2 more
  • Mobile, Alabama
  • +26 more
Jan 27, 2023

Emergencies Trial (GeneXpert®)

Withdrawn
  • Emergencies
  • GeneXpert®
  • (no location specified)
Nov 9, 2020

Antistaphylococcal Betalactam and Emergence of Resistance

Completed
  • Bacterial Resistance
  • Methicillin-Sensitive Staphylococcus Aureus Infection
    • Nancy, Lorraine, France
      Lefevre
    Jul 1, 2023

    Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis Trial in Montreal (Ertapenem, Placebo)

    Not yet recruiting
    • Staphylococcus Aureus Bacteremia
    • +3 more
    • Montreal, Quebec, Canada
      McGill University Health Centre (Royal Victoria Hospital and Mon
    Feb 21, 2022

    Methicillin-resistant Staphylococcus Aureus, Skin Infection Trial in Sylmar, Torrance, Saint Louis (TMP-SMX, DOXY)

    Recruiting
    • Methicillin-resistant Staphylococcus Aureus
    • Skin Infection
    • Sylmar, California
    • +2 more
    Jul 1, 2021

    Methicillin-resistant Staphylococcus Aureus Trial in United States (Standard-of-Care Education, MRSA Decolonization)

    Completed
    • Methicillin-resistant Staphylococcus Aureus
    • Standard-of-Care Education
    • MRSA Decolonization
    • Aliso Viejo, California
    • +23 more
    Sep 27, 2021

    Methicillin-resistant Staphylococcus Aureus Trial in Saint John (Rifampin, Doxycycline, 2% mupirocin ointment)

    Completed
    • Methicillin-resistant Staphylococcus Aureus
    • Saint John, New Brunswick, Canada
      Saint John Regional Hospital
    Feb 12, 2020

    Methicillin-Resistant Staphylococcus Aureus Trial (intervention)

    Completed
    • Methicillin-Resistant Staphylococcus Aureus
    • intervention
    • (no location specified)
    Mar 26, 2020

    MRSA, Cystic Fibrosis Trial in Canada, United States (Vancomycin inhalation powder, Placebo inhalation powder)

    Completed
    • MRSA
    • Cystic Fibrosis
    • Vancomycin inhalation powder
    • Placebo inhalation powder
    • Mobile, Alabama
    • +70 more
    Nov 4, 2021

    Staphylococcus Aureus, Carbapenem Resistant Gram Negative Bacteria Trial (Targeted gown and gloves use)

    Not yet recruiting
    • Staphylococcus Aureus
    • Carbapenem Resistant Gram Negative Bacteria
    • Targeted gown and gloves use
    • (no location specified)
    Oct 26, 2021

    Patients With Infection by Resistant Microorganism

    Enrolling by invitation
    • Pneumonia
    • +10 more
    • Pathogen resistant phenotype
    • Sevilla, Spain
      Hospital Universitario Virgen Macarena
    May 18, 2023

    Gram-negative Bacilli and MRSA Screening in ICU in China

    Unknown status
    • Infections, Bacterial
    • None intervention. This is an observational study.
    • Hangzhou, Zhejiang, China
      Sir Run Run Shaw Hospital
    Mar 18, 2020

    Staphylococcus Aureus Trial in Philadelphia (Bacillus subtilis probiotic, Placebo)

    Unknown status
    • Staphylococcus Aureus
    • Bacillus subtilis probiotic
    • Placebo
    • Philadelphia, Pennsylvania
      Rothman Institute
    Feb 18, 2020

    Patients withInfections Caused by S.Aureus Like Skin Infections , Chest Infections , Surgical Site Infections , and Urinary

    Not yet recruiting
    • Patients withInfections Caused by S.Aureus Like Skin Infections , Chest Infections , Surgical Site Infections , and Urinary Tract Infections
    • antibiotic sensitivity
    • Sohag, Egypt
      Sohag University Hospital
    Apr 13, 2023